Raymond James Financial’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.49M Sell
162,026
-205,265
-56% -$2.29M ﹤0.01% 3710
2026
Q1
$3.98M Sell
367,291
-220,112
-37% -$1.88M ﹤0.01% 2783
2025
Q4
$3.59M Sell
587,403
-14,082
-2% -$84.1K ﹤0.01% 2784
2025
Q3
$3.12M Sell
601,485
-18,830
-3% -$108K ﹤0.01% 2824
2025
Q2
$3.68M Sell
620,315
-427,771
-41% -$2.58M ﹤0.01% 2585
2025
Q1
$8.62M Buy
1,048,086
+351,325
+50% +$2.95M ﹤0.01% 1928
2024
Q4
$5.75M Buy
+696,761
New +$5.59M ﹤0.01% 2233

Other funds holding PTEN

Raymond James Financial's PTEN Position: Q2 2026 in Review

Raymond James Financial reduced its Patterson-UTI (PTEN) stake by 56% in Q2 2026, selling an estimated $2.29M and leaving 162,026 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #3710.

Raymond James Financial first reported a position in PTEN in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.62M in Q1 2025. 439 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Raymond James Financial held 162,026 shares of Patterson-UTI worth $1.49M as of Q2 2026.
  • Raymond James Financial sold 205,265 Patterson-UTI shares in Q2 2026, an estimated $2.29M.
  • Patterson-UTI made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3710 holding.
  • Raymond James Financial first reported a position in Patterson-UTI in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Patterson-UTI position peaked at $8.62M in Q1 2025.
  • 439 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.